About DermaSensor
DermaSensor is a company based in Miami (United States) founded in 2009 by Christopher Dewey.. DermaSensor has raised $60.75 million across 6 funding rounds from investors including Ceros Capital Markets, David Matlin and Chris Dewey. DermaSensor offers products and services including DermaSensor Device. DermaSensor operates in a competitive market with competitors including MedLumics, Zerigo Health, SciBase, Hememics Biotechnologies and DAMAE Medical, among others.
- Headquarter Miami, United States
- Founders Christopher Dewey
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Dermasensor, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$60.75 M (USD)
in 6 rounds
-
Latest Funding Round
$16 M (USD), Series B
Oct 02, 2025
-
Investors
Ceros Capital Markets
& 7 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of DermaSensor
DermaSensor offers a comprehensive portfolio of products and services, including DermaSensor Device. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Handheld AI device for non-invasive skin cancer risk assessment.
Unlock access to complete
Unlock access to complete
Funding Insights of DermaSensor
DermaSensor has successfully raised a total of $60.75M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $16 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series B — $16.0M
-
First Round
First Round
(18 Dec 2018)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2025 | Amount | Series B - DermaSensor | Valuation |
investors |
|
| Nov, 2024 | Amount | Series B - DermaSensor | Valuation |
investors |
|
| Jun, 2022 | Amount | Series B - DermaSensor | Valuation | Ceros Capital Markets |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in DermaSensor
DermaSensor has secured backing from 8 investors, including venture fund and angel investors. Prominent investors backing the company include Ceros Capital Markets, David Matlin and Chris Dewey. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are focused on tech startups.
|
Founded Year | Domain | Location | |
|
VC and investment banking firm backed by Aegis Capital Corp
|
Founded Year | Domain | Location | |
|
Early-stage technology companies are funded by Miami Angels.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by DermaSensor
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - DermaSensor
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Dermasensor Comparisons
Competitors of DermaSensor
DermaSensor operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MedLumics, Zerigo Health, SciBase, Hememics Biotechnologies and DAMAE Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biological tissue imaging is developed using optical coherence tomography.
|
|
| domain | founded_year | HQ Location |
Developer of UVB light therapy devices for monitoring Psoriasis, Vitiligo, and Eczema
|
|
| domain | founded_year | HQ Location |
Point-of-care device for malignant melanoma detection is provided.
|
|
| domain | founded_year | HQ Location |
Biopreservation platform for mammalian cells and biologics is developed.
|
|
| domain | founded_year | HQ Location |
Non-invasive 3D imaging devices for skin cancer diagnostics are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Dermasensor
Frequently Asked Questions about DermaSensor
When was DermaSensor founded?
DermaSensor was founded in 2009 and raised its 1st funding round 9 years after it was founded.
Where is DermaSensor located?
DermaSensor is headquartered in Miami, United States. It is registered at Miami, Florida, United States.
Is DermaSensor a funded company?
DermaSensor is a funded company, having raised a total of $60.75M across 6 funding rounds to date. The company's 1st funding round was a Series B of $10M, raised on Dec 18, 2018.
What does DermaSensor do?
DermaSensor was founded in 2009 and is based in Miami, United States. A handheld diagnostic device for skin cancer is developed by the company within the medical diagnostics sector. Skin lesions are evaluated using elastic scattering spectroscopy, where a light-emitting tip captures cellular irregularities below the surface. Immediate high-risk or low-risk results are provided through proprietary algorithms analyzing reflected photons.
Who are the top competitors of DermaSensor?
DermaSensor's top competitors include SciBase, MedLumics and Hememics Biotechnologies.
What products or services does DermaSensor offer?
DermaSensor offers DermaSensor Device.
Who are DermaSensor's investors?
DermaSensor has 8 investors. Key investors include Ceros Capital Markets, David Matlin, Chris Dewey, SternAegis Ventures, and Miami Angels.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.